Alcohol‐related hepatitis admissions increased 50% in the first months of the COVID‐19 pandemic in the USA. (24th February 2022)

• Record Type: Journal Article
• Authors: Gonzalez, Humberto C.; Zhou, Yueren; Nimri, Faisal M.; Rupp, Loralee B.; Trudeau, Sheri; Gordon, Stuart C.
• Is Part Of: Liver international. Volume 42:Number 4(2022)
• Page Start: 762
• Page End: 764
• Publication Date: 2022-02-24
• Subjects: alcohol‐related liver disease -- alcoholic hepatitis -- cirrhosis -- hospitalization -- SARS‐CoV‐2; Liver -- Periodicals; Liver -- Diseases -- Periodicals; 616.362
• DOI: 10.1111/liv.15172
• Languages: English
• ISSNs: 1478-3223

Abstract

Abstract: Early reports suggest that alcohol misuse increased in 2020 as a result of the COVID‐19 pandemic. Using retrospective data from Henry Ford Health System in Detroit MI—an area that experienced an early and severe COVID‐19 outbreak—we investigated the impact of the pandemic on alcohol‐related liver disease (ARLD) in the summer of 2020 compared with the same period in 2016‐2019. Both the number of ARLD admissions and the proportion of total admissions represented by ARLD patients increased significantly in 2020 compared with previous years. The number of ARLD admissions as a proportion of all hospitalizations was 50% higher in 2020 than in 2016‐2019 (0.31% vs 0.21%; P = .0013); by September 2020, the number of admissions was 66% higher than previous years. Despite racial and geographical disparities in direct and indirect COVID‐related stressors across the Detroit metropolitan area, the demographic profile of ARLD patients did not change compared with previous years.